The hospital’s infrastructure includes approximately 240 patient rooms, 48 intensive care beds, seven operating theatres, and two catheterisation laboratories, enabling staff to deliver care across more than 40 specialized medical disciplines.
The 22 national standards, which include two pre-standards developed in 2024, specifically address the safe deployment of AI technologies in medical environments.
The partnership between these companies stems from a late 2024 licensing agreement in which Corxel obtained worldwide rights to CX11, excluding China, from Vincentage.
Four districts across two regions were affected: Jinka, Malle, and Arba Minch in the South Ethiopia Region, and Hawassa in the Sidama Region.
The local production of dydrogesterone represents not only an important milestone for Mubadala Bio and Bioventure Healthcare but also a timely contribution to supporting women’s health throughout the country.
The Spectra Optia Apheresis Machine performs red cell exchange, a specialized procedure that removes damaged red blood cells from patients and replaces them with healthy ones.
The streamlined process allows patients to start their Invisalign treatment faster while significantly improving office efficiency and enhancing the overall patient experience.
NMC will deploy Opus across its facilities to improve decision-making processes, streamline clinical and administrative workflows, and support better patient outcomes.
The merger has already cleared several regulatory hurdles, having secured approval from the Competition Commission of India (CCI) and received ‘No Objection’ letters from the Stock Exchanges.
The grant will enable Qure.ai to develop a comprehensive open-source multi-modal database designed to accelerate future prevention and identification innovations.